Navigation Links
Abbott's Humira(r) (Adalimumab) Gets Approval by EU for Crohn's Disease Treatment

ABBOTT PARK, Ill., Abbott announced today that it has received marketing authorization from the European Commission for the use of HUMIRA(R) (adalimumab) as a treatment for severe Crohn's disease. HUMIRA is the first self-administered biologic for the treatment of Crohn's disease and offers an effective and convenient treatment option that can help enable patients to maintain control of their disease. This announcement follows FDA approval for the Crohn's disease indication, which Abbott received in February, and is the fourth approved indication for HUMIRA in the United States and the European Union.

Crohn's disease is a serious, chronic, inflammatory disease of the gastrointestinal (GI) tract that affects more than 1 million people in North America and Europe. It affects people of all ages, but it is primarily a disease of young adults, with onset typically before age 40. There is no medical or surgical cure for Crohn's disease and few treatment options exist for patients suffering with this chronic condition.

"Crohn's can have a devastating impact on patients, many of whom are young and active, making it difficult to carry out normal day-to-day activities," said Rod Mitchell, chairman, European Federation of Crohn's & Ulcerative Colitis Associations. "The unpredictable nature of the disease can seriously impact their quality of life and self-esteem. For the half million people across Europe suffering from Crohn's, this approval offers hope to help them regain control of their disease."

Common symptoms of Crohn's disease include diarrhea, cramping, abdominal pain, weight loss, fever, and in some cases, rectal bleeding. Complications include intestinal obstruction, fistulas (ulcers that form tunnels to surrounding tissues), and malnutrition. Over the course of their disease, as many as 75 percent of patients with Crohn's disease will undergo surgery at least once for complications or disease resistant to treatment. Of thos
'"/>




Page: 1 2

Related medicine news :

1. Approval for DNA test to detect cystic fibrosis
2. Vaccine For Cervical Cancer Awaits Approval
3. WHO Gives Its Approval For Bird Flu Test Kit
4. FDA Gives Its Approval For Inhaler
5. RotaTeq Gets US Approval
6. Better Communication With FDA Could Speed Up Approval Of New Drugs
7. Nerve Stimulator for Depression Though Not Effective Was Given Approval
8. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
9. Global Education Net Pvt Medical College Gets MCI Approval
10. Approval of Drugs for the Treatment of Late-Stage Cancer
11. Lupin Gets USFDA Approval For Quinapril Tablets
Post Your Comments:
(Date:3/30/2015)... Dr. Shahdad Arami is now offering ... $200 off their Invisalign treatment. Many people crave straighter ... mouthful of metal. Invisalign offers an alternative. According to ... effective for straightening teeth but has no aesthetic value ... appearance. The Invisalign system allows both teenagers and adults ...
(Date:3/30/2015)... On March 27th, 2015, 24Hr HomeCare ... inspire courage in Seth Lane, a five-year-old boy from ... SCID causes affected individuals to be susceptible to life-threatening ... allow the development of functional immune systems. Lane, ... video with his family requesting its viewers to wear ...
(Date:3/30/2015)... V/NO (Virtually No Alcohol) Wines have a sleek single-serve ... for reuse. Consumers simply twist the cup, turn it upward ... and basically anyone can now enjoy a non-alcoholic wine ... or pair with meals at work, home, or wherever the ... and that means Napa Wine grapes undergo the traditional wine ...
(Date:3/30/2015)... 2015 Software applications from five ... the second AS4 test and certification event, announced ... in interoperability software testing. New software applications from ... participated in this vendor-neutral test event which began ... interoperability certifications for IBM, Oracle and Software AG, ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Corra Group is ... accommodate the needs of every industry that requires this form ... compliance mandates or seek new ways to increase productivity and ... drug panels that will help detect substance abuse with a ... mandated drug tests,” said Corra Group Co-Founder, Gordon Basichis. ...
Breaking Medicine News(10 mins):Health News:Northridge Cosmetic Dentist, Dr. Arami, is Now Offering a New Promotion on Invisalign 2Health News:24Hr HomeCare Staff Hosts #WearYellowForSeth Campaign for Five-Year-Old Boy with Severe Combined Immunodeficiency 2Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:Latest AS4 Standard-Based Products Drummond Certified™ 2Health News:Latest AS4 Standard-Based Products Drummond Certified™ 3Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 2Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 3
... WASHINGTON, Sept. 24 Benjamin England,Special Counsel with ... Rural Development, Food and Drug Administration, and Related,Agencies, ... September,25, 2007 at 10:00 a.m. in Room 2362A ... focus on the on the Food & Drug ...
... advances in diabetes care, African Americans and Latinos are ... blood sugar under control, even with the help of ... them at a much higher risk of blindness, heart ... complications. , The comprehensive new national study of ...
... of the,House Nancy Pelosi (D-CA) and Representatives ... introduced the Coordinated Environmental,Public Health Network Act ... public health tracking network to allow for ... adverse health effects and,environmental hazards, and increase ...
... host more than 200 physicians and emergency medicine technicians ... Conference, Sept. 26-28. Those attending will learn how to ... circumstances encountered in the wilderness., The emergency medical system ... New York City and the 2005 Hurricane Katrina disaster ...
... being,issued by Rosa Acuna and Harold J. Cassidy: WHAT: Filing ... Jersey Supreme Court as last ... in the historic informed consent abortion,case will be filing a motion ... Jersey Supreme Court in which that court held,that a physician can ...
... More than 1 million consumers impacted by information to make ... ... Sept. 24 Massachusetts employers and health,plans have successfully completed ... Excellence (BTE) programs, the nation,s,largest effort to reward physicians for ...
Cached Medicine News:Health News:Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee 2Health News:Older blacks and Latinos still lag whites in controlling diabetes 2Health News:Older blacks and Latinos still lag whites in controlling diabetes 3Health News:Older blacks and Latinos still lag whites in controlling diabetes 4Health News:Older blacks and Latinos still lag whites in controlling diabetes 5Health News:Pelosi, Slaughter and Tubbs Jones Introduce Health Tracking Legislation 2Health News:Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court 2Health News:Massachusetts Employers and Health Plans Continue to Support Quality Care by Rewarding Physicians through Bridges to Excellence Programs 2Health News:Massachusetts Employers and Health Plans Continue to Support Quality Care by Rewarding Physicians through Bridges to Excellence Programs 3
(Date:3/30/2015)... , March 30, 2015  The investigational S- ... alleviate certain menopause symptoms, such as hot flashes, according ... Journal of Women,s Health .[i] "Current data ... equol for menopausal vasomotor symptoms and possibly additional benefits, ... of S- equol, physicians and health care professionals ...
(Date:3/30/2015)... March 30, 2015  A promising University of Michigan ... with a rare and lethal subtype of leukemia has ... with a new biotechnology company, Kura Oncology.  The Leukemia ... led by Assistant Professor Jolanta Grembecka , Ph.D, ... the University of Michigan, since 2009. ...
(Date:3/30/2015)... MINNEAPOLIS and ORANGEBURG, N.Y., March 30, 2015 ... Inc. (NASDAQ: VSCI ) shareholders have voted ... held today to approve the previously announced agreement ... "We are pleased with the outcome ... to thank both shareholder groups for approving the ...
Breaking Medicine Technology:New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 2New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 3New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 6Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4